Characterization of the human EPLIN (Epithelial Protein Lost in Neoplasm) gene reveals distinct promoters for the two EPLIN isoforms

被引:34
作者
Chen, SX
Maul, RS
Kim, HR
Chang, DD
机构
[1] Univ Calif Los Angeles, Sch Med, Div Heme Onc,Jonsson Comprehens Canc Ctr, Dept Med Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dent Res Inst, Los Angeles, CA 90095 USA
关键词
alternative RNA processing; immediate-early gene; serum response element;
D O I
10.1016/S0378-1119(00)00144-X
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
EPLIN is a novel LIM domain protein that co-localizes to the actin stress fibers and focal adhesion plaques. We previously have demonstrated that two isoforms, the 600 aa EPLIN-alpha and the 759 aa EPLIN-beta, are generated from a single gene. In the majority of human breast and prostate cancer cell lines, the expression of EPLIN-a is significantly reduced, while the expression of EPLIN-beta is either up-regulated or unchanged. To understand the basis of this differential regulation, we have determined the organization of the human EPLIN gene. The human EPLIN gene spans > 100 kb and consists of 11 exons. The EPLIN-beta mRNA requires all 11 exons, while the EPLIN-a mRNA requires Exons 4-11. The transcriptional start sites of EPLIN-a were mapped within the third intron by 5' RACE and Si nuclease protection. Similarly, the 5' ends of EPLIN-beta were mapped upstream of Exon 1. The DNA sequences flanking the EPLIN-alpha or EPLIN-beta transcriptional start sites were capable of stimulating the expression of promoter reporter constructs. Interestingly, the endogenous transcription of EPLIN-a, but not EPLIN-beta, could be stimulated by serum, indicating that the expression of two EPLIN isoforms can be independently regulated. A consensus serum response element was present within 100 bp upstream of the transcriptional start sites of EPLIN-alpha. The activity of 0.7 kb EPLIN-alpha promoter reporter construct could be enhanced by activated RhoA, indicating that this serum response element is functional. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 10 条
  • [1] Characterization of transformation related genes in oral cancer cells
    Chang, DD
    Park, NH
    Denny, CT
    Nelson, SF
    Pe, M
    [J]. ONCOGENE, 1998, 16 (15) : 1921 - 1930
  • [2] THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY
    COSO, OA
    CHIARIELLO, M
    YU, JC
    TERAMOTO, H
    CRESPO, P
    XU, NG
    MIKI, T
    GUTKIND, JS
    [J]. CELL, 1995, 81 (07) : 1137 - 1146
  • [3] LIM domains: multiple roles as adapters and functional modifiers in protein interactions
    Dawid, IB
    Breen, JJ
    Toyama, R
    [J]. TRENDS IN GENETICS, 1998, 14 (04) : 156 - 162
  • [4] Specificity within the ets family of transcription factors
    Graves, BJ
    Petersen, JM
    [J]. ADVANCES IN CANCER RESEARCH, VOL 75, 1998, 75 : 1 - 55
  • [5] THE RHO-FAMILY GTPASES RHOA, RAC1, AND CDC42HS REGULATE TRANSCRIPTIONAL ACTIVATION BY SRF
    HILL, CS
    WYNNE, J
    TREISMAN, R
    [J]. CELL, 1995, 81 (07) : 1159 - 1170
  • [6] Limatin (LIMAB1), an actin-binding LIM protein, maps to mouse chromosome 19 and human chromosome 10q25, a region frequently deleted in human cancers
    Kim, AC
    Peters, LL
    Knoll, JHM
    VanHuffel, C
    Ciciotte, SL
    Kleyn, PW
    Chishti, AH
    [J]. GENOMICS, 1997, 46 (02) : 291 - 293
  • [7] EPLIN, Epithelial protein lost in neoplasm
    Maul, RS
    Chang, DD
    [J]. ONCOGENE, 1999, 18 (54) : 7838 - 7841
  • [8] STRUCTURE OF THE CARBOXY-TERMINAL LIM DOMAIN FROM THE CYSTEINE-RICH PROTEIN CRP
    PEREZALVARADO, GC
    MILES, C
    MICHELSEN, JW
    LOUIS, HA
    WINGE, DR
    BECKERLE, MC
    SUMMERS, MF
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (06): : 388 - 398
  • [9] DdLIM is a cytoskeleton-associated protein involved in the protrusion of lamellipodia in Dictyostelium
    Prassler, J
    Murr, A
    Stocker, S
    Faix, J
    Murphy, J
    Marriott, G
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (03) : 545 - 559
  • [10] Treisman R, 1990, Semin Cancer Biol, V1, P47